Phenprocoumon

6 trials 4 recruiting BHaematology

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

1 Completed trials

5 Sponsors

8 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 3

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Atrial fibrillation 2 Aortic valve replacement 1

Sponsors using this IMP

Hamilton Health Sciences Corporation 2 Icahn School Of Medicine At Mount Sinai 1 Medical University Of Graz 1 St Antonius Hospital 1 St. Antonius Ziekenhuis 1

All trials

6 total

Anticoagulant medicines for Balloon Pulmonary Angioplasty Pending

2024-518803-23-00 Phase IV 1 country St. Antonius Ziekenhuis
The Direct Oral Anticoagulation versus Vitamin K Antagonist after Cardiac Surgery (DANCE) Trial Recruiting

2023-504504-28-00 Phase III 1 country Hamilton Health Sciences Corporation
Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting

2023-504637-42-01 Phase IV 5 countries St Antonius Hospital
Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with… Recruiting

2024-515924-35-00 Phase IV 1 country Icahn School Of Medicine At Mount Sinai
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Recruiting

2023-508532-56-00 Phase III 6 countries Hamilton Health Sciences Corporation
Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI (ST-ele… Ended

2022-500383-35-00 Phase II 1 country Medical University Of Graz

Showing 1–6 of 6 trials

← All drugs A–Z